Chemotherapy in locally advanced rectal cancer (LARC) is shifting from an adjuvant setting to a total neoadjuvant therapy (TNT) strategy, that relies on distant metastases (DM) risk prediction. This study… Click to show full abstract
Chemotherapy in locally advanced rectal cancer (LARC) is shifting from an adjuvant setting to a total neoadjuvant therapy (TNT) strategy, that relies on distant metastases (DM) risk prediction. This study aims to assess the accuracy of magnetic resonance imaging‐detected extramural vascular invasion (mrEMVI) as predictive factor for DM in LARC, compared with other MRI‐detected and pathologic factors.
               
Click one of the above tabs to view related content.